![]() | Up a level |
Article
Kyu, Hmwe Hmwe, Maddison, Emilie R, Henry, Nathaniel J, Ledesma, Jorge R, Wiens, Kirsten E, Reiner Jr, Robert, Biehl, Molly H, Shields, Chloe, OsgoodZimmerman, Aaron, Ross, Jennifer M, Carter, Austin, Frank, Tahvi D, Wang, Haidong, Srinivasan, Vinay, Deribe, Kebede, GBD Tuberculosis Collaborators, and others, (2018) Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. The Lancet Infectious Diseases, 18 (12). pp. 1329-1349. ISSN 1473-3099
Middleton, Jo, Cassell, Jackie, Jones, Christopher I, Lanza, Stefania, Head, Michael G and Walker, Stephen L (2018) Authors reply to ‘Scabies control: the forgotten role of personal hygiene’, correspondence by Duncan Mara. The Lancet Infectious Diseases, 18 (10). pp. 1068-1069. ISSN 1473-3099
Cassell, Jackie A, Middleton, Jo, Nalabanda, Ananth, Lanza, Stefania, Head, Michael G, Bostock, Jennifer, Hewitt, Kirsty, Jones, Christopher Iain, Darley, Charles, Karir, Simran and Walker, Stephen L (2018) Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. The Lancet Infectious Diseases, 18 (8). pp. 894-902. ISSN 1473-3099
Eziefula, Alice C (2016) Artesunate–mefloquine: a malaria treatment for African children? The Lancet Infectious Diseases, 16 (10). pp. 1086-1087. ISSN 14733099
Bousema, Teun, Eziefula, Alice C, Pett, Helmi and Drakeley, Chris (2014) Low-dose primaquine for falciparum malaria. The Lancet Infectious Diseases, 14 (8). p. 677. ISSN 1473-3099
Eziefula, Alice C, Bousema, Teun, Yeung, Shunmay, Kamya, Moses, Owaraganise, Asiphas, Gabagaya, Grace, Bradley, John, Grignard, Lynn, Lanke, Kjerstin H W, Wanzira, Humphrey, Mpimbaza, Arthur, Nsobya, Samuel, White, Nicholas J, Webb, Emily L, Staedke, Sarah G and Drakeley, Chris (2014) Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. The Lancet Infectious Diseases, 14 (2). pp. 130-139. ISSN 1473-3099